ArticleEuropean geriatric medicine2026
Could the Geriatric Mobile Team trial (GerMoT) inclusion criteria be a pragmatic approach to identifying older adults who may be a relevant target group for integrated care interventions?
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purposePatients with the traditional definition of multimorbidity, with 2 or more chronic diseases, are a very large and heterogeneous group who differ considerably depending on which set of disorders they suffer from. This paper describes the baselines characteristics of the GerMoT cohort and investigates if the GerMoT inclusion criteria could be used to identify a subgroup of multimorbid patients who may be considered a relevant target group for integrated care interventions.
methodParticipants were 75 years or older, had 3 or more visits to the Emergency Department in the last 18 months, had 3 or more diseases diagnosed according to different ICD-10 chapters and lived in their own home. GerMoT is a randomized-controlled trial comparing proactive outpatient care based on Comprehensive Geriatric Assessment with usual care. The participant's living arrangements, frailty, grip strength, cognition, physical activity, activities of daily living, quality of life, and physical performance were recorded at baseline.
results450 participants were included with a mean age of 83 years (range 75-100); 54% were female. 54% of the cohort lived alone and 44% needed some home adaptation to manage at home. This group had high levels of multimorbidity with a mean of 7.2 (SD = 2.5) diagnoses in different ICD-10 chapters per patient and suffered from pain (80%) and mobility issues (64%). However, they had low levels of frailty (60% non-frail, 13% severely frail) and 90% were independent or partially independent with basic ADLs.
conclusionThe GerMoT inclusion criteria could be a pragmatic way to identify a subgroup of multimorbid people with frequent emergency department use who may be considered a relevant target group for integrated care interventions.
Indexed as
Identifiers
42503160What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.